WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 1049

Legislative bill overview

SB 1049 is a Hawaii bill focused on Parkinson's disease research, currently in early legislative stages after passing first reading. The bill has been referred to the Health and Human Services (HHS) and Ways and Means (WAM) committees for review. Specific provisions of the bill are not detailed in the available action summary, so the precise scope of research initiatives, funding mechanisms, or policy changes cannot be determined from this information alone.

Why is this important

Parkinson's disease affects over 1 million Americans and represents a significant public health burden with substantial economic costs. Legislative focus on Parkinson's research could lead to increased funding, improved treatment options, or enhanced disease management infrastructure in Hawaii. Research initiatives may ultimately benefit patients through better diagnostics, therapeutics, or healthcare access improvements.

Potential points of contention

  • Funding source and amount - Whether the bill creates new appropriations or redirects existing resources remains unclear; budget constraints may generate debate in WAM committee
  • Research scope and priorities - Questions may arise about which research areas receive emphasis (basic science, clinical trials, patient care) and whether priorities align with stakeholder interests
  • Implementation feasibility - Determining how research will be conducted (through existing institutions, new centers, or partnerships) and whether Hawaii has adequate infrastructure and expertise

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.